Contracting of a civil liability insurance policy for the clinical trial titled Allogeneic Mesenchymal Stem Cells (MSC) for Ocular Injection as Therapy for Graft-versus-Host Disease (GvHD) Refractory to Conventional Treatments.
About This Opportunity
Director Científico del Instituto de Investigación Biomédica de Salamanca (IBSAL) | 7,500.00 EUR
This is a services contract in the health and medical services and finance and banking sectors, with a focus on Mental Health and Insurance. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 7,500.
Published through PLACSP - Plataforma de Contratación del Sector Público, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from SpanishTender ID: PRCNIBSAL/ICI23/00027/NORA/02/2026 (2026/08); Contracting Authority: Scientific Director of the Salamanca Biomedical Research Center (IBSAL); Amount: 7500 EUR; Status: PUB
Data provenance
This notice is sourced from PLACSP - Plataforma de Contratación del Sector Público and was originally published on July 29, 2026. Last refreshed 27 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Director Científico del Instituto de Investigación Biomédica de Salamanca (IBSAL)
Director Científico del Instituto de Investigación Biomédica de Salamanca (IBSAL) has issued 8 procurement notices on BidsFactory, including 0 currently open and 4 awarded contracts. Activity concentrates in Governance & Public Administration, Research & Innovation, and Health & Medical. All notices are published for Spain. Notices are distributed via PLACSP - Plataforma de Contratación del Sector Público. Most recent publication: July 29, 2026.
Frequently asked questions about this tender
How much was the contract awarded for?
CHUBB EUROPEAN GROUP SE, Sucursal en España was awarded the contract for €4,326. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit PLACSP - Plataforma de Contratación del Sector Público to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to CHUBB EUROPEAN GROUP SE, Sucursal en España. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Director Científico del Instituto de Investigación Biomédica de Salamanca (IBSAL) in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Key Details
Contracting Authority
Companies That Won Similar
Companies with awards in Health & Medical in Spain